AbCellera Biologics Company
AbCellera Biologics is a biotechnology company that develops antibody therapeutics to improve patient outcomes.
Investors
Connections from
Founded Date:
2012-01-01
Last Funding Type:
Series B
Headquarters:
Vancouver, British Columbia, Canada
Investors Number:
12.0
Employee Number:
101-250
Industry:
Early Drug Development
Estimated Revenue:
$10M to $50M
Last Funding Date:
2020-05-27
Funding Status:
IPO
Total Funding:
371217878.0